Pharmacological treatment of obesity in patients with polycystic ovary syndrome

Hassan Kahal, Stephen Atkin, Thozhukat Sathyapalan

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed.

Original languageEnglish
Article number402052
JournalJournal of Obesity
Volume2011
DOIs
Publication statusPublished - 2011
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this